News

Royce Small-Cap Trust (RVT) Declares Quarterly Stock Distribution

Royce Small-Cap Trust (RVT) Declares Quarterly Stock Distribution

Royce Small-Cap Trust Makes Important Distribution Announcement

Royce Small-Cap Trust, Inc. (NYSE: RVT) has made a significant announcement regarding its quarterly distribution for shareholders. The company will provide a distribution of $0.29 per share on its Common Stock. This distribution gives shareholders the option to receive either additional shares of Common Stock or cash, depending on their preference during the election period.

Payment Schedule and Details

This distribution is set to be paid on a announced date, with shareholders of record being those counted at the end of business on September 12. The ex-dividend date falls on the same day, meaning that shareholders must purchase their shares before that date to qualify for this payment. The price of shares for reinvestment will be determined shortly after the ex-dividend date.

Distribution Policy Overview

The Fund has a structured distribution policy of providing quarterly payments on its Common Stock. Currently, the Fund aims to distribute at an annual rate of 7% based on the rolling average net asset values (NAVs) of the previous four quarterly periods. It's important to note that the fourth quarter distribution will be determined based on the greater of either 1.75% of the average or the minimum legally required distribution according to IRS regulations. This policy can be adjusted at the discretion of the Board of Directors, ensuring flexibility in managing distributions.

Insights on Fund Sources

For this upcoming distribution, the Fund has outlined estimated sources that will help fulfill the payment due. These sources are crucial for understanding where the funds to pay the distribution will be allocated from. The figures have been prepared with estimates reflecting the Fund's financial health and investment activities, up to the end of a recent period.

Performance and Allocation Metrics

The Fund's allocations as reported for the year 2025 showcase a detailed breakdown of the sources of the distribution. This includes net investment income, net realized short-term and long-term gains, and return of capital. The breakdown serves as an informative guide for investors looking to understand the sustainability of their investments amidst market fluctuations.

Distribution Breakdown Details

The detailed portion of distributions includes figures such as net investment income of $0.0106 per share amounting to a 4% contribution, net realized short-term gains contributing $0.0193 per share which denotes 6%, and significant returns of capital showcasing 90% contribution at $0.2601 per share. Additionally, understanding these allocations helps investors decipher how their investment returns are structured, which is essential when planning future investments.

Understanding Fund Performance Metrics

The performance metrics of the Royce Small-Cap Trust are indicative of its long-term growth strategy. The Fund primarily focuses on small-cap companies, allocating more than 80% of its assets into equity of businesses that meet small-cap classifications. This involves companies within a specific market capitalization range, ensuring alignment with the overall investment strategy.

Long-Term Growth Objectives

With this investment approach, Royce Small-Cap Trust aims for capital growth and sustainability. Over extended periods, the compounding effects of reinvested distributions contribute to wealth accumulation for shareholders. Keeping abreast of performance across multiple years helps in understanding patterns in the market, positioning the Fund favorably amongst its peers.

Conclusion and Future Outlook

In summary, the declaration of a $0.29 distribution per share by Royce Small-Cap Trust is a strong indicator of the Fund's commitment to its shareholders and its ability to navigate market challenges effectively. As changes in policy occur, it is vital for investors to monitor announcements and performance metrics closely to make informed decisions in their financial endeavors.

Frequently Asked Questions

What is the announced distribution amount for Royce Small-Cap Trust?

The announced distribution amount is $0.29 per share for shareholders of Royce Small-Cap Trust.

When will the payment be made to shareholders?

The payment is scheduled to be made on a set date to shareholders recorded by the end of business on September 12.

How often does Royce Small-Cap Trust pay distributions?

Royce Small-Cap Trust pays distributions quarterly to its shareholders.

What options do shareholders have regarding the distribution?

Shareholders can opt to receive the distribution in either cash or additional shares of Common Stock.

What is the Fund's investment focus?

The Fund focuses on small-cap companies, investing over 80% of its assets in their equity securities to achieve long-term capital growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 352

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 377

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

YouTube Shuts Down Tenet Media Channel Amid Legal Issues

Updated Category News Views 305

YouTube's Action Against Tenet Media Explained YouTube, which is part of Alphabet (NASDAQ: GOOGL), has made a significant move by shutting down the Tenet Media channel, along with four other channels managed by Lauren Chen. This decision comes in response to serious legal actions taken by the U.S. Department of Justice against certain individuals involved in money...

Continue Reading
Ardelyx Faces Class Action Lawsuit Amidst Investment Losses

Updated Category News Views 112

Important Update for Ardelyx Investors Regarding Class Action Pomerantz LLP has recently informed shareholders about a class action lawsuit involving Ardelyx, Inc. This lawsuit targets both the company and its key officers, alleging violations of federal securities laws. Investors who held Ardelyx securities during a specified timeframe should pay close attention to this...

Continue Reading
Derek Bryson Park: Innovator Transforming Finance Worldwide

Updated Category News Views 205

Celebrating Derek Bryson Park's Impact on Finance Derek Bryson Park has recently been highlighted by The Enterprise World Magazine as a key figure in the financial industry, a well-deserved recognition for his extensive and impactful career. With three decades of experience, Park continues to innovate in finance, public service, and global diplomacy. Pioneering Leadership...

Continue Reading
Understanding Currency Impacts in Global Trade Dynamics

Updated Category News Views 291

Understanding Currency Impacts in Global Trade Dynamics Scott Bessent, a noted figure in finance, is igniting conversations regarding tariffs and trade in recent discussions. All eyes on Wall Street are focused on how these changes influence market dynamics. Initially, any reduction in the U.S. trade deficit with other nations may seem like a significant win for the...

Continue Reading
Pennant Group Expands Its Operations with Recent Acquisition

Updated Category News Views 283

Pennant Group's Strategic Acquisition Announcement The Pennant Group, Inc. (NASDAQ: PNTG), a prominent holding company in the healthcare industry, recently achieved a significant milestone by acquiring specific operational assets from UnitedHealth Group Incorporated. This notable transaction was made possible due to UnitedHealth’s acquisition of Amedisys Inc., enabling...

Continue Reading